Selective precipitation of prions by polyoxometalate complexes

被引:83
作者
Lee, IS
Long, JR [1 ]
Prusiner, SB
Safar, JG
机构
[1] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
[2] Univ Calif San Francisco, Inst Neurodegenerat Dis, Dept Neurol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
关键词
D O I
10.1021/ja055219y
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The efficacy of a variety of polyoxometalate anions in selectively precipitating the infectious isoform of the prion protein (PrPSc) over the normal, cellular protein (PrPC) was tested as a means of improving the sensitivity of a conformation-dependent immunoassay (CDI). Experiments utilizing neutralized aqueous solutions containing MgCl2·6H2O and Na2H[PW12O40] (1) indicated that use of the former is detrimental to selectivity, while use of the latter gives optimal selectivity at a concentration of 2.48% w/v, much higher than the 0.31% w/v employed in the current CDI protocol. Similar experiments using Na4[SiW12O40] (2), K5[BW12O40] (3), and Na6[H2W12O40] (4) were performed to probe the role of charge density in polyoxometalate anions possessing the Keggin structure. These, coupled with assignment of solution structures via NMR and infrared spectroscopy, revealed the following trend in optimal concentrations: [HBW11O39]8- < [SiW11O39]8- < [PW11O39]7- = [H2W12O40]6-. Interestingly, use of the salts K10[Zn4(H2O)2(PW9O34)2] (5), Na16[Zn4(H2O)2(P2W15O56)2] (6), and Na27[NaAs4W40O140] (7), containing larger polyoxometalate anions, was found to suppress PrPSc precipitation in a concentration-dependent manner. Taken together, the results suggest a precipitation mechanism wherein Keggin-type anions link multiple PrPSc moieties by binding a somewhat hindered cleft featuring one or more positively charged residues. Copyright © 2005 American Chemical Society.
引用
收藏
页码:13802 / 13803
页数:2
相关论文
共 16 条
[1]  
BURSTEIN M, 1982, LIPOPROTEIN PRECIPIT
[2]   ANTI-HIV-1 ACTIVITY, TOXICITY, AND STABILITY STUDIES OF REPRESENTATIVE STRUCTURAL FAMILIES OF POLYOXOMETALATES [J].
HILL, CL ;
WEEKS, MS ;
SCHINAZI, RF .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (10) :2767-2772
[3]   Prevalence of lymphoreticular prion protein accumulation in UK tissue samples [J].
Hilton, DA ;
Ghani, AC ;
Conyers, L ;
Edwards, P ;
McCardle, L ;
Ritchie, D ;
Penney, M ;
Hegazy, D ;
Ironside, JW .
JOURNAL OF PATHOLOGY, 2004, 203 (03) :733-739
[4]  
JONES RM, 1993, Patent No. 5213965
[5]   Polyoxometalate HIV-1 protease inhibitors. A new mode of protease inhibition [J].
Judd, DA ;
Nettles, JH ;
Nevins, N ;
Snyder, JP ;
Liotta, DC ;
Tang, J ;
Ermolieff, J ;
Schinazi, RF ;
Hill, CL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (05) :886-897
[6]   Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion [J].
Llewelyn, CA ;
Hewitt, PE ;
Knight, RSG ;
Amar, K ;
Cousens, S ;
Mackenzie, J ;
Will, RG .
LANCET, 2004, 363 (9407) :417-421
[7]   Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient [J].
Peden, AH ;
Head, MW ;
Ritchie, DL ;
Bell, JE ;
Ironside, JW .
LANCET, 2004, 364 (9433) :527-529
[8]  
PRUSINER SB, 1999, Patent No. 5977324
[9]  
PRUSINER SB, 2000, Patent No. 6166187
[10]   Polyoxometalates in medicine [J].
Rhule, JT ;
Hill, CL ;
Judd, DA .
CHEMICAL REVIEWS, 1998, 98 (01) :327-357